Next-Level Neuroscience Innovations Unveiled
🧠In this week’s Neuroscience Updates, we explore five game-changing developments shaking up biotech and pharma—from MS therapies and an Alzheimer’s blood test breakthrough to cutting-edge AI surgery tech and more!
Key updates include:
💊 Sanofi’s Tolebrutinib delays disability progression by 31% in non-relapsing SPMS
🧪 Quest Diagnostics launches AD-Detect to aid early Alzheimer’s diagnosis.
🤖 Proprio’s AI-powered Paradigm platform gains FDA clearance
🧬 Lilly & Sangamo announce a $1.4B deal for CNS therapies
💸 Immunic raises $5.1M to support MS and autoimmune trials
📢 Stay Ahead in Neuroscience Research!
✅ Like, share, and subscribe for weekly updates on Neuroscience
#Neuroscience #MSResearch #Alzheimers #GeneTherapy #AIinHealthcare #BiotechNews #LucidQuest #HealthcareInnovation #NeuroTech #ClinicalTrials